AUIN

Anterior cruciate ligament (ACL) injury is the most common intra-articular lesion in the knee. The loss of capsular, tendon and ligament tissue of the joints and / or musculoskeletal tissue, constitute lesions that are difficult to repair by means of their own regeneration. Due to the inability of these tissues to renew themselves, grafts from localities close to or distant from injured ones (autogenous grafts) are chosen, but the morbidity due to the removal of these grafts or the pain where the graft was removed become common complications the use of this material. The use of allografts or allogeneic transplants of the mentioned structures is also applied in some hospitals, restricted to limited supply, in addition to possible sites of bacterial infection or even transmission of other infectious diseases, or of a possible immune response in the host organism. The third and final treatment option for possible lesions are synthetic prostheses, which, although approved by the FDA, are not recommended for primary ACL reconstruction because they fail because of fragmentation that may eventually lead to arthritis and synovy.

The present invention allows a wide evolution in the field of repair of capsular, tendon and ligament injuries. In cases of anterior cruciate ligament injuries of the knee, the described technique allows the biological regeneration of injured tissues with fast, efficient, immediate and cost-effective treatments in the repair of these lesions. The result is obtained without damage to the musculoskeletal tissue, occurring as an innovation of the past techniques, that is, a new tissue is added to the organism without the association of mutilation of other structures. It: promotes regeneration of ligaments and tendons; uses biocompatible material to any patient (avoids immune rejection); uses biodegradable material; promotes quick and efficient treatment and simple procedure at a reduced cost.